SCHEMBL45870

SCHEMBL45870

CCc1nnc(CC)nn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16625933 0.86
SCHEMBL21257038 0.83
SCHEMBL2614743 0.82 HRH4 (0.33)
SCHEMBL10074498 0.81
Hydrochloric Acid SCHEMBL28946231 0.75 HRH4 (0.31)
SCHEMBL10271455 0.71 KDM4E (0.42)
SCHEMBL8755416 0.70 HSP90AA1 (0.31)
SCHEMBL14050809 0.70
SCHEMBL8755276 0.70 HSP90AA1 (0.31)
SCHEMBL10353126 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114761613-B Selective deposition of passivation films 应用材料公司 2024-11-29 CN claimed
CN-114761613-A Selective deposition of passivation films 应用材料公司 2022-07-15 CN claimed
CN-114761613-B Selective deposition of passivation films 应用材料公司 2024-11-29 CN disclosed
US-11857636-B2 Bio-orthogonal drug activation TAGWORKS PHARMACEUTICALS B.V. (NL) 2024-01-02 US disclosed
US-11857636-B2 Bio-orthogonal drug activation TAGWORKS PHARMACEUTICALS B.V. (NL) 2024-01-02 US disclosed
US-20230323072-A1 METHOD FOR CLEAVING COORDINATE BOND OF COMPLEX POLYMER BRIDGESTONE CORPORATION (JP) 2023-10-12 US disclosed
US-20230322965-A1 COMPLEX POLYMER, RUBBER COMPOSITION, METHOD FOR MANUFACTURING RUBBER COMPOSITION, AND RUBBER PRODUCT BRIDGESTONE CORPORATION (JP) 2023-10-12 US disclosed
EP-4245744-A2 CHEMICALLY CLEAVABLE GROUP Tagworks Pharmaceuticals B.V. (NL) 2023-09-20 EP disclosed
EP-2922574-B1 CHEMICALLY CLEAVABLE GROUP TAGWORKS PHARMACEUTICALS B V (NL) 2023-05-17 EP disclosed
CN-114761613-A Selective deposition of passivation films 应用材料公司 2022-07-15 CN disclosed
EP-2709667-B1 BIO-ORTHOGONAL DRUG ACTIVATION TAGWORKS PHARMACEUTICALS B V (NL) 2022-04-13 EP disclosed
US-20120142680-A1 HETEROALKYL LINKED PYRIMIDINE DERIVATIVES S*BIO PTE LTD. (SG) 2012-06-07 US disclosed
US-8153632-B2 Oxygen linked pyrimidine derivatives S*BIO PTE LTD. (SG) 2012-04-10 US disclosed
US-8143255-B2 Heteroalkyl linked pyrimidine derivatives S*BIO PTE LTD. (SG) 2012-03-27 US disclosed
US-8067403-B2 Methods and systems for preparing an antimicrobial composition ALLACCEM, INC. (US) 2011-11-29 US disclosed
US-20110015300-A1 METHODS AND SYSTEMS FOR COATING A SURFACE ALLACCEM, INC. 2011-01-20 US disclosed
US-20090258886-A1 HETEROALKYL LINKED PYRIMIDINE DERIVATIVES S*BIO PTE LTD. (SG) 2009-10-15 US disclosed
US-20090074833-A1 BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR CONTROLLING BONE RESORPTION ALLACCEM, INC. 2009-03-19 US disclosed
US-20090075999-A1 OXYGEN LINKED PYRIMIDINE DERIVATIVES S*BIO PTE LTD. (SG) 2009-03-19 US disclosed
US-20080275141-A1 BRIDGED POLYCYCLIC COMPOUND BASED COMPOSITIONS FOR THE INHIBITION AND AMELIORATION OF DISEASE ALLACCEM, INC. 2008-11-06 US disclosed